etanercept
ItalyDrugs containing this active substance
-
This medicine is used to reduce inflammation associated with certain diseases, such as rheumatoid arthritis (moderate to severe), psoriatic arthritis, axial spondyloarthritis (including ankylosing spondylitis), and plaque psoriasis (moderate to severe). It is also used in children and adolescents for specific forms of arthritis and psoriasis, provided they weigh 62.5 kg or more.
Form: solution for injection
Active substance Dosage etanercept - ATC: L04AB01
Manufacturer: SAMSUNG BIOEPIS NL B.V.
-
Enbrel is used for the treatment of rheumatoid arthritis (moderate to severe), psoriatic arthritis, severe axial spondyloarthritis (including ankylosing spondylitis), and psoriasis (moderate to severe) in adults. It is also prescribed for certain types of juvenile idiopathic arthritis and severe psoriasis in children and adolescents.
Form: powder for solution for injection
Active substance Dosage etanercept - ATC: L04AB01
Manufacturer: PFIZER EUROPE MA EEIG
-
Erelzi is used for the treatment of rheumatoid arthritis (moderate to severe), psoriatic arthritis, severe axial spondyloarthritis (including ankylosing spondylitis), and moderate to severe psoriasis in adults. It is also prescribed for certain types of juvenile idiopathic arthritis and severe psoriasis in children and adolescents weighing 62.5 kg or more.
Form: solution for injection
Active substance Dosage etanercept - ATC: L04AB01
Manufacturer: SANDOZ GMBH
-
Nepexto is used for the treatment of several inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis (including ankylosing spondylitis), and moderate to severe psoriasis. It can also be used in children and adolescents for specific forms of juvenile idiopathic arthritis and severe psoriasis, depending on body weight and medical prescription.
Form: solution for injection
Active substance Dosage etanercept - ATC: L04AB01
Manufacturer: BIOSIMILAR COLLABORATIONS IRELAND LIMITED